HK Stocks in Focus: PEIJIA-B (09996) Rises Over 3% After NMPA Approves GeminiOne® TEER System Registration

Stock News

Yesterday

Shares of PEIJIA-B (09996) climbed more than 3% in Hong Kong trading on Wednesday, with the stock last changing hands at HK$4.915, up 3.04%, on turnover of approximately HK$3.17 million.

The move comes after the company announced on September 11 that its independently developed GeminiOne® transcatheter edge-to-edge repair (TEER) system had recently received registration approval from China's National Medical Products Administration (NMPA).

The approval of GeminiOne® marks the group's official entry into the commercial treatment space for mitral regurgitation, significantly expanding its transcatheter valve therapy product portfolio beyond its existing footprint in aortic stenosis and aortic regurgitation treatments.

Regarding regulatory progress, the application for EU MDR CE marking of GeminiOne® has been submitted, while the US early feasibility study for the device is currently underway.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/news/1196914865"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1196914865\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1196914865?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 15:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196914865","market":"other","top_or_hot":-1,"title":"HK Stocks in Focus: PEIJIA-B (09996) Rises Over 3% After NMPA Approves GeminiOne® TEER System Registration","media":"Stock News","content":"<p>Shares of <b>PEIJIA-B (09996)</b> climbed more than 3% in Hong Kong trading on Wednesday, with the stock last changing hands at HK$4.915, up 3.04%, on turnover of approximately HK$3.17 million.<br><br>The move comes after the company announced on September 11 that its independently developed GeminiOne® transcatheter edge-to-edge repair (TEER) system had recently received registration approval from China's National Medical Products Administration (NMPA).<br><br>The approval of GeminiOne® marks the group's official entry into the commercial treatment space for mitral regurgitation, significantly expanding its transcatheter valve therapy product portfolio beyond its existing footprint in aortic stenosis and aortic regurgitation treatments.<br><br>Regarding regulatory progress, the application for EU MDR CE marking of GeminiOne® has been submitted, while the US early feasibility study for the device is currently underway.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Stocks in Focus: PEIJIA-B (09996) Rises Over 3% After NMPA Approves GeminiOne® TEER System Registration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Stocks in Focus: PEIJIA-B (09996) Rises Over 3% After NMPA Approves GeminiOne® TEER System Registration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-14 15:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>PEIJIA-B (09996)</b> climbed more than 3% in Hong Kong trading on Wednesday, with the stock last changing hands at HK$4.915, up 3.04%, on turnover of approximately HK$3.17 million.<br><br>The move comes after the company announced on September 11 that its independently developed GeminiOne® transcatheter edge-to-edge repair (TEER) system had recently received registration approval from China's National Medical Products Administration (NMPA).<br><br>The approval of GeminiOne® marks the group's official entry into the commercial treatment space for mitral regurgitation, significantly expanding its transcatheter valve therapy product portfolio beyond its existing footprint in aortic stenosis and aortic regurgitation treatments.<br><br>Regarding regulatory progress, the application for EU MDR CE marking of GeminiOne® has been submitted, while the US early feasibility study for the device is currently underway.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159891","symbol_name":"医疗","start_time":0,"source_url":"","article_id":"1196914865","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196914865","pubTimestamp":1789370765,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of PEIJIA-B (09996) climbed more than 3% in Hong Kong trading on Wednesday, with the stock last changing hands at HK$4.915, up 3.04%, on turnover of approximately HK$3.17 million.The move...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159891":"医疗","BK1583":"高瓴概念","VXUS":"国际股票ETF-Vanguard","KCAI":"KraneShares China Alpha Index ETF","BK4588":"碎股","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","BK1574":"生物医药B类股","09996":"沛嘉医疗-B"},"translate_title":"港股焦点：NMPA批准GeminiOne后培佳B（09996）上涨逾3%®TEER系统注册","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"KCAI":1,"VXUS":1,"09996":1},"content_text":"Shares of PEIJIA-B (09996) climbed more than 3% in Hong Kong trading on Wednesday, with the stock last changing hands at HK$4.915, up 3.04%, on turnover of approximately HK$3.17 million.The move comes after the company announced on September 11 that its independently developed GeminiOne® transcatheter edge-to-edge repair (TEER) system had recently received registration approval from China's National Medical Products Administration (NMPA).The approval of GeminiOne® marks the group's official entry into the commercial treatment space for mitral regurgitation, significantly expanding its transcatheter valve therapy product portfolio beyond its existing footprint in aortic stenosis and aortic regurgitation treatments.Regarding regulatory progress, the application for EU MDR CE marking of GeminiOne® has been submitted, while the US early feasibility study for the device is currently underway.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}